Where Neuroscience and Precision Medicine Meet

Scientific Approach

Copenhagen-based Biopharmaceutical Company

TETRAPHARM is a Danish biopharmaceutical company that specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system to treat neurological diseases and mental health disorders.

Alongside a strong, growing R&D pipeline, TETRAPHARM offers end-to-end CDMO services built around our proprietary drug delivery technology, ZYNDIKATE®, helping partners develop scalable and clinically robust pharmaceutical products.

  • Scientific Approach

    Scientific Approach

    We advance CNS therapies through neuroscience and drug delivery innovation

    Learn more
  • R&D Pipeline

    R&D Pipeline

    At present, we have multiple candidates intended for obesity (with neurological focus), chronic pain, Alzheimer’s and mental health disorders in our clinical pipeline

    Learn more

  • CDMO

    With our ZYNDIKATE®-enabled CDMO solutions, we take you from early development to full-scale production and commercialization

    Learn more

  • At TETRAPHARM, we believe that real innovation starts by asking the right questions. ​

    We focus on root causes rather than just symptomatic relief.

    That is why our work is guided by a simple philosophy:

    Think in systems. Think beyond symptoms.

    Learn more

  • Improving Quality of Life Through Science

    TETRAPHARM specializes in the development of pharmaceutical drugs aimed at the central nervous system (CNS) and the immune system to treat neurological diseases and mental health disorders

    Learn more

  • Science at the Forefront

    Science drives everything TETRAPHARM does as we continue to address unmet needs within neurological diseases and mental health disorders targeting the Central Nervous System (CNS)

    Learn more

  • Conscious About Our Role in Society

    We are dedicated to operating as a sustainable business and are committed to making a positive impact on the world around us

    Learn more

  • News

    Keep updated on all the latest news and press releases from TETRAPHARM

    learn more